Resources from the same session
2111 - Phase III randomized study of neoadjuvant chemotherapy (CT) with docetaxel(D), oxaliplatin(O) and S-1(S) (DOS) followed by surgery and adjuvant S-1, vs surgery and adjuvant S-1, for resectable advanced gastric cancer (GC) (PRODIGY)
Presenter: Yoon-Koo Kang
Session: Proffered Paper 2 – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
3635 - Perioperative Chemotherapy of Oxaliplatin Combined with S-1 (SOX) versus Postoperative Chemotherapy of SOX or Oxaliplatin with Capecitabine (XELOX) in Locally Advanced Gastric Adenocarcinoma with D2 Gastrectomy: a Randomized Phase III Trial (RESOLVE Trial)
Presenter: Jiafu Ji
Session: Proffered Paper 2 – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
4088 - Randomized phase 3 ANGEL study of rivoceranib (apatinib) + best supportive care (BSC) vs placebo + BSC in patients with advanced/metastatic gastric cancer who failed _2 prior chemotherapy regimens
Presenter: Yoon-Koo Kang
Session: Proffered Paper 2 – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast
6259 - Pembrolizumab With or Without Chemotherapy vs Chemotherapy in Patients With Advanced G/GEJ Cancer (GC) Including Outcomes According to Microsatellite Instability-High (MSI-H) Status in KEYNOTE-062
Presenter: Kohei Shitara
Session: Proffered Paper 2 – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Proffered Paper 2 – Gastrointestinal tumours, non-colorectal - Invited Discussant LBA43 and LBA44
Presenter: Kei Muro
Session: Proffered Paper 2 – Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast